BrainsWay Ltd. (BWAY)
USD 8.78
(-3.3%)
USD 8.78
(-3.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 23.09 Million USD | 15.18% |
| 2022 | 20.04 Million USD | -13.05% |
| 2021 | 23.05 Million USD | 35.64% |
| 2020 | 16.99 Million USD | -5.41% |
| 2019 | 17.97 Million USD | 40.32% |
| 2018 | 12.8 Million USD | 49.8% |
| 2017 | 8.55 Million USD | -6.01% |
| 2016 | 9.09 Million USD | 70.55% |
| 2015 | 5.33 Million USD | 95.81% |
| 2014 | 2.72 Million USD | 175.15% |
| 2013 | 990 Thousand USD | 211.14% |
| 2012 | 318.18 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 7.53 Million USD | 10.64% |
| 2024 Q1 | 6.81 Million USD | 1.08% |
| 2023 FY | 23.09 Million USD | 15.18% |
| 2023 Q2 | 5.73 Million USD | 18.64% |
| 2023 Q1 | 4.83 Million USD | 12.29% |
| 2023 Q4 | 6.73 Million USD | 9.2% |
| 2023 Q3 | 6.17 Million USD | 7.62% |
| 2022 Q1 | 6.1 Million USD | -7.02% |
| 2022 FY | 20.04 Million USD | -13.05% |
| 2022 Q4 | 4.3 Million USD | 12.46% |
| 2022 Q3 | 3.82 Million USD | -34.18% |
| 2022 Q2 | 5.81 Million USD | -4.74% |
| 2021 Q3 | 6.13 Million USD | 7.47% |
| 2021 Q1 | 4.6 Million USD | -16.25% |
| 2021 FY | 23.05 Million USD | 35.64% |
| 2021 Q2 | 5.7 Million USD | 23.86% |
| 2021 Q4 | 6.56 Million USD | 7.06% |
| 2020 Q2 | 3.82 Million USD | 21.83% |
| 2020 Q4 | 5.5 Million USD | 21.44% |
| 2020 FY | 16.99 Million USD | -5.41% |
| 2020 Q1 | 3.14 Million USD | -35.22% |
| 2020 Q3 | 4.52 Million USD | 18.31% |
| 2019 Q4 | 4.85 Million USD | 1.49% |
| 2019 Q2 | 4.31 Million USD | 7.33% |
| 2019 FY | 17.97 Million USD | 40.32% |
| 2019 Q1 | 4.02 Million USD | 9.74% |
| 2019 Q3 | 4.77 Million USD | 10.65% |
| 2018 Q4 | 3.66 Million USD | 8.85% |
| 2018 Q3 | 3.36 Million USD | 17.63% |
| 2018 FY | 12.8 Million USD | 49.8% |
| 2018 Q2 | 2.86 Million USD | -1.51% |
| 2018 Q1 | 2.9 Million USD | 8.06% |
| 2017 Q2 | 1.82 Million USD | 7.17% |
| 2017 Q4 | 2.69 Million USD | 15.25% |
| 2017 Q3 | 2.33 Million USD | 28.09% |
| 2017 Q1 | 1.7 Million USD | -19.35% |
| 2017 FY | 8.55 Million USD | -6.01% |
| 2016 Q1 | 2.01 Million USD | 16.93% |
| 2016 FY | 9.09 Million USD | 70.55% |
| 2016 Q4 | 2.1 Million USD | -23.53% |
| 2016 Q3 | 2.75 Million USD | 24.51% |
| 2016 Q2 | 2.21 Million USD | 9.93% |
| 2015 FY | 5.33 Million USD | 95.81% |
| 2015 Q4 | 1.72 Million USD | 16.06% |
| 2015 Q3 | 1.48 Million USD | 26.71% |
| 2015 Q1 | 3.92 Million USD | 297.59% |
| 2015 Q2 | 1.17 Million USD | -70.14% |
| 2014 Q4 | 986.94 Thousand USD | 48.65% |
| 2014 FY | 2.72 Million USD | 175.15% |
| 2014 Q1 | 1.85 Million USD | 241.43% |
| 2014 Q3 | 663.94 Thousand USD | 8.69% |
| 2014 Q2 | 610.87 Thousand USD | -67.12% |
| 2013 Q3 | 223.45 Thousand USD | 79.75% |
| 2013 Q4 | 544.18 Thousand USD | 143.53% |
| 2013 FY | 990 Thousand USD | 211.14% |
| 2013 Q1 | 122.04 Thousand USD | 17.14% |
| 2013 Q2 | 124.31 Thousand USD | 1.86% |
| 2012 Q3 | 73.73 Thousand USD | 0.0% |
| 2012 FY | 318.18 Thousand USD | 0.0% |
| 2012 Q4 | 104.18 Thousand USD | 41.31% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -805.529% |
| Cerus Corporation | 86.4 Million USD | 73.274% |
| Envoy Medical, Inc. | -473 Thousand USD | 4981.818% |
| electroCore, Inc. | 13.22 Million USD | -74.588% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -37754.098% |
| IceCure Medical Ltd | 1.3 Million USD | -1676.231% |
| Inogen, Inc. | 126.69 Million USD | 81.775% |
| OrthoPediatrics Corp. | 111.25 Million USD | 79.245% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 481.669% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 48881.055% |
| MaxCyte, Inc. | 36.54 Million USD | 36.817% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -4958.081% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -27046.72% |
| Orthofix Medical Inc. | 486.27 Million USD | 95.251% |
| PAVmed Inc | -3.96 Million USD | 681.93% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 520.985% |
| RxSight, Inc. | 53.76 Million USD | 57.052% |
| Sight Sciences, Inc. | 69.17 Million USD | 66.619% |
| SI-BONE, Inc. | 109.42 Million USD | 78.897% |
| TELA Bio, Inc. | 40.11 Million USD | 42.434% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 84.802% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -179.18% |
| Acutus Medical, Inc. | -3.13 Million USD | 836.085% |
| Talis Biomedical Corporation | 371 Thousand USD | -6123.989% |
| Spectral AI, Inc. | 7.88 Million USD | -193.033% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 450.288% |
| CVRx, Inc. | 33.03 Million USD | 30.11% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -3022.405% |
| Bioventus Inc. | 328.19 Million USD | 92.964% |
| Venus Concept Inc. | 52.16 Million USD | 55.736% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -45.172% |
| LivaNova PLC | 771.25 Million USD | 97.006% |
| 908 Devices Inc. | 25.32 Million USD | 8.811% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 92.556% |
| Nemaura Medical Inc. | -1.47 Million USD | 1664.016% |
| NeuroPace, Inc. | 48.12 Million USD | 52.016% |
| LENSAR, Inc. | 21.1 Million USD | -9.4% |
| Apyx Medical Corporation | 14.12 Million USD | -63.511% |
| Cutera, Inc. | 41.49 Million USD | 44.351% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -25.08% |
| BioSig Technologies, Inc. | 18 Thousand USD | -128183.333% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 77.601% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -69.612% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 97.401% |
| Axonics, Inc. | 274.55 Million USD | 91.59% |
| Outset Medical, Inc. | 29 Million USD | 20.376% |
| IRIDEX Corporation | 21.8 Million USD | -5.888% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 67.5% |
| IRadimed Corporation | 50.15 Million USD | 53.964% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -7945.645% |
| INVO Bioscience, Inc. | 1.08 Million USD | -2025.973% |
| Telesis Bio, Inc. | 16.95 Million USD | -36.23% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 79.526% |
| Varex Imaging Corporation | 256.9 Million USD | 91.012% |
| Quipt Home Medical Corp. | 163.84 Million USD | 85.907% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 5787.438% |
| Pulmonx Corporation | 50.75 Million USD | 54.502% |
| Dynatronics Corporation | 7.63 Million USD | -202.437% |
| Modular Medical, Inc. | -768 Thousand USD | 3106.641% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -316.204% |
| Semler Scientific, Inc. | 61.2 Million USD | 62.27% |
| InMode Ltd. | 411.34 Million USD | 94.386% |
| Bruker Corporation | 1.51 Billion USD | 98.478% |
| Cytosorbents Corporation | 22.39 Million USD | -3.122% |
| DexCom, Inc. | 2.28 Billion USD | 98.991% |
| Align Technology, Inc. | 2.71 Billion USD | 99.151% |
| Viveve Medical, Inc. | 620 Thousand USD | -3624.355% |
| ZimVie Inc. | 290.38 Million USD | 92.048% |
| Movano Inc. | -158 Thousand USD | 14714.557% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 78.898% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -27046.72% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 93.72% |
| Profound Medical Corp. | 4.51 Million USD | -411.539% |
| Insulet Corporation | 1.15 Billion USD | 98.009% |
| enVVeno Medical Corporation | -546 Thousand USD | 4329.121% |
| Surmodics, Inc. | 93.05 Million USD | 75.185% |
| iCAD, Inc. | 14.53 Million USD | -58.854% |
| Nuwellis, Inc. | 4.98 Million USD | -363.396% |
| Biotricity, Inc. | 8.35 Million USD | -176.331% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 93.041% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 6531.012% |
| InspireMD, Inc. | 1.8 Million USD | -1177.864% |
| PAVmed Inc. | -3.96 Million USD | 681.93% |
| BIOLASE, Inc. | 16.72 Million USD | -38.071% |
| Beyond Air, Inc. | -1.3 Million USD | 1866.718% |
| FONAR Corporation | 45.14 Million USD | 48.846% |
| AxoGen, Inc. | 127.87 Million USD | 81.942% |
| Vivani Medical, Inc. | -357 Thousand USD | 6568.067% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 88.167% |
| Inari Medical, Inc. | 434.56 Million USD | 94.686% |
| UFP Technologies, Inc. | 112.22 Million USD | 79.424% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -184347.64% |
| Tenon Medical, Inc. | 1.24 Million USD | -1760.677% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 28607.407% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -778.958% |
| AdaptHealth Corp. | 479.56 Million USD | 95.185% |
| Sintx Technologies, Inc. | 1.84 Million USD | -1152.903% |
| NanoVibronix, Inc. | 1.53 Million USD | -1402.342% |
| Quanterix Corporation | 70.64 Million USD | 67.314% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 5787.438% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -64.232% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 56.25% |
| TransMedics Group, Inc. | 154.09 Million USD | 85.015% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -418.549% |
| NeuroMetrix, Inc. | 3.94 Million USD | -484.965% |
| Hyperfine, Inc. | 4.75 Million USD | -385.411% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 78.415% |
| Biomerica, Inc. | 611 Thousand USD | -3679.214% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 44.609% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 3056.764% |
| Silk Road Medical, Inc | 127.08 Million USD | 81.83% |